{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:19:48Z","timestamp":1790014788348,"version":"4.0.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY029823"],"award-info":[{"award-number":["EY029823"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"DOI":"10.1186\/s12868-025-00971-7","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T15:32:58Z","timestamp":1755703978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hybrid molecule SA-10 and its PLGA nanosuspension protect human and rodent retinal ganglion cells against neuronal injury"],"prefix":"10.1186","volume":"26","author":[{"given":"Jennifer H.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Tuyen T.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Kodati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Amankwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biddut","family":"DebNath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien T.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Y.","family":"Gitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah P.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon R.","family":"Hatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rojan","family":"Satyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella R.","family":"Sinnott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu R.","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchismita","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota L.","family":"Stankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"11","key":"971_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390.","journal-title":"Ophthalmology"},{"issue":"3","key":"971_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mcna.2021.01.004","volume":"105","author":"JM Kang","year":"2021","unstructured":"Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021;105(3):493\u2013510.","journal-title":"Med Clin North Am"},{"issue":"6","key":"971_CR3","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1167\/iovs.15-18469","volume":"57","author":"P Gupta","year":"2016","unstructured":"Gupta P, Zhao D, Guallar E, Ko F, Boland MV, Friedman DS. Prevalence of glaucoma in the United States: the 2005\u20132008 national health and nutrition examination survey. Investig Ophthalmol Vis Sci. 2016;57(6):2905\u201313.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"10","key":"971_CR4","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.ophtha.2007.06.013","volume":"114","author":"A Hennis","year":"2007","unstructured":"Hennis A, Wu SY, Nemesure B, Honkanen R, Leske MC. Awareness of incident open-angle glaucoma in a population study: the Barbados eye studies. Ophthalmology. 2007;114(10):1816\u201321.","journal-title":"Ophthalmology"},{"issue":"Suppl1","key":"971_CR5","first-page":"S19","volume":"59","author":"Y Pan","year":"2011","unstructured":"Pan Y, Varma R. Natural history of glaucoma. Indian J Ophthalmol. 2011;59(Suppl1):S19\u201323.","journal-title":"Indian J Ophthalmol"},{"key":"971_CR6","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.2147\/IJN.S254792","volume":"15","author":"S Kwon","year":"2020","unstructured":"Kwon S, Kim SH, Khang D, Lee JY. Potential therapeutic usage of nanomedicine for glaucoma treatment. Int J Nanomed. 2020;15:5745\u201365.","journal-title":"Int J Nanomed"},{"issue":"1","key":"971_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10792-017-0795-9","volume":"39","author":"K Evangelho","year":"2019","unstructured":"Evangelho K, Mogilevskaya M, Losada-Barragan M, Vargas-Sanchez JK. Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature. Int Ophthalmol. 2019;39(1):259\u201371.","journal-title":"Int Ophthalmol"},{"key":"971_CR8","first-page":"60","volume":"6","author":"Y Munemasa","year":"2012","unstructured":"Munemasa Y, Kitaoka Y. Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection. Front Cell Neurosci. 2012;6:60.","journal-title":"Front Cell Neurosci"},{"key":"971_CR9","unstructured":"Kolb H. Morphology and Circuitry of Ganglion Cells. In: Kolb H, Fernandez E, Nelson R, editors. Webvision: The Organization of the Retina and Visual System. Salt Lake City (UT): University of Utah Health Sciences Center. 1995."},{"key":"971_CR10","doi-asserted-by":"publisher","first-page":"102400","DOI":"10.1016\/j.nano.2021.102400","volume":"35","author":"L Hinkle","year":"2021","unstructured":"Hinkle L, Le D, Nguyen T, Tran V, Amankwa CE, Weston C, et al. Nano encapsulated novel compound SA-10 with therapeutic activity in both acute and chronic murine hindlimb ischemia models. Nanomedicine. 2021;35:102400.","journal-title":"Nanomedicine"},{"issue":"2","key":"971_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.exer.2010.09.002","volume":"93","author":"D Schmidl","year":"2011","unstructured":"Schmidl D, Garhofer G, Schmetterer L. The complex interaction between ocular perfusion pressure and ocular blood flow - relevance for glaucoma. Exp Eye Res. 2011;93(2):141\u201355.","journal-title":"Exp Eye Res"},{"issue":"3","key":"971_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ohc.2005.04.002","volume":"18","author":"MH Kuehn","year":"2005","unstructured":"Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am. 2005;18(3):383\u201395. vi.","journal-title":"Ophthalmol Clin North Am"},{"issue":"2","key":"971_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40123-017-0094-6","volume":"6","author":"J Aliancy","year":"2017","unstructured":"Aliancy J, Stamer WD, Wirostko B. A review of nitric oxide for the treatment of glaucomatous disease. Ophthalmol Ther. 2017;6(2):221\u201332.","journal-title":"Ophthalmol Ther"},{"key":"971_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.exer.2016.08.006","volume":"151","author":"B Mead","year":"2016","unstructured":"Mead B, Tomarev S. Evaluating retinal ganglion cell loss and dysfunction. Exp Eye Res. 2016;151:96\u2013106.","journal-title":"Exp Eye Res"},{"issue":"1\u20132","key":"971_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/jop.2017.0041","volume":"34","author":"S He","year":"2018","unstructured":"He S, Stankowska DL, Ellis DZ, Krishnamoorthy RR, Yorio T. Targets of neuroprotection in glaucoma. J Ocul Pharmacol Ther. 2018;34(1\u20132):85\u2013106.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"971_CR16","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1111\/aos.13568","volume":"96","author":"F Li","year":"2018","unstructured":"Li F, Huang W, Zhang X. Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis. Acta Ophthalmol. 2018;96(3):e277\u201384.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"971_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/ceo.13336","volume":"47","author":"C Guymer","year":"2019","unstructured":"Guymer C, Wood JP, Chidlow G, Casson RJ. Neuroprotection in glaucoma: recent advances and clinical translation. Clin Exp Ophthalmol. 2019;47(1):88\u2013105.","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"971_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/2008-322X.183914","volume":"11","author":"J Mallick","year":"2016","unstructured":"Mallick J, Devi L, Malik PK. Update on normal tension glaucoma. J Ophthalmic Vis Res. 2016;11(2):204\u20138.","journal-title":"J Ophthalmic Vis Res"},{"key":"971_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2147\/OPTH.S162999","volume":"12","author":"AA Kondkar","year":"2018","unstructured":"Kondkar AA, Sultan T, Almobarak FA, Kalantan H, Al-Obeidan SA, Abu-Amero KK. Association of increased levels of plasma tumor necrosis factor alpha with primary open-angle glaucoma. Clin Ophthalmol. 2018;12:701\u20136.","journal-title":"Clin Ophthalmol"},{"key":"971_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0079-6123(08)01128-X","volume":"173","author":"G Tezel","year":"2008","unstructured":"Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog Brain Res. 2008;173:409\u201321.","journal-title":"Prog Brain Res"},{"key":"971_CR21","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.preteyeres.2021.100998","volume":"87","author":"G Tezel","year":"2022","unstructured":"Tezel G. Molecular regulation of neuroinflammation in glaucoma: current knowledge and the ongoing search for new treatment targets. Prog Retin Eye Res. 2022;87:100998.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"971_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0891-5849(03)00437-4","volume":"35","author":"E Fernandes","year":"2003","unstructured":"Fernandes E, Toste SA, Lima JL, Reis S. The metabolism of Sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radic Biol Med. 2003;35(9):1008\u201317.","journal-title":"Free Radic Biol Med"},{"key":"971_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejphar.2016.03.064","volume":"787","author":"R Russo","year":"2016","unstructured":"Russo R, Varano GP, Adornetto A, Nucci C, Corasaniti MT, Bagetta G, et al. Retinal ganglion cell death in glaucoma: exploring the role of neuroinflammation. Eur J Pharmacol. 2016;787:134\u201342.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"971_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40478-022-01427-3","volume":"10","author":"C Rutigliani","year":"2022","unstructured":"Rutigliani C, Tribble JR, Hagstrom A, Lardner E, Johannesson G, Stalhammar G, et al. Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients. Acta Neuropathol Commun. 2022;10(1):118.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"971_CR25","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1167\/iovs.14-14515","volume":"55","author":"ME Cavet","year":"2014","unstructured":"Cavet ME, Vittitow JL, Impagnatiello F, Ongini E, Bastia E. Nitric oxide (NO): an emerging target for the treatment of glaucoma. Investig Ophthalmol Vis Sci. 2014;55(8):5005\u201315.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"971_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.niox.2018.04.010","volume":"77","author":"LK Wareham","year":"2018","unstructured":"Wareham LK, Buys ES, Sappington RM. The nitric oxide-guanylate cyclase pathway and glaucoma. Nitric Oxide. 2018;77:75\u201387.","journal-title":"Nitric Oxide"},{"issue":"8","key":"971_CR27","first-page":"538","volume":"62","author":"S Acharya","year":"2021","unstructured":"Acharya S, Acha LG, Gondi S, Dibas A, Amankwa C, Roth S, et al. The anti-inflammatory and neuroprotective activity of novel hybrid molecule SA-10 in in vitro ischemic models. Investig Ophthalmol Vis Sci. 2021;62(8):538.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"971_CR28","doi-asserted-by":"crossref","unstructured":"Amankwa CE, Gondi SR, Dibas A, Weston C, Funk A, Nguyen T et al. Novel thiol containing hybrid Antioxidant-Nitric oxide donor small molecules for treatment of glaucoma. Antioxid (Basel). 2021;10(4).","DOI":"10.3390\/antiox10040575"},{"key":"971_CR29","unstructured":"Pham J. Structure and proposed mechanisms of action of SA-10. Created in BioRender; 2025 [cited 2025 Aug 10]. Available from: https:\/\/biorender.com\/y50f624"},{"key":"971_CR30","doi-asserted-by":"publisher","first-page":"107016","DOI":"10.1016\/j.ejps.2025.107016","volume":"206","author":"CE Amankwa","year":"2025","unstructured":"Amankwa CE, DebNath B, Pham JH, Johnson GA, Zhang W, Ranjan A, et al. Optimized PLGA encapsulated SA-2 nanosuspension exhibits sustained intraocular pressure reduction in the mouse microbead occlusion model of ocular hypertension. Eur J Pharm Sci. 2025;206:107016.","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"971_CR31","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1167\/iovs.18-25999","volume":"60","author":"DL Stankowska","year":"2019","unstructured":"Stankowska DL, Dibas A, Li L, Zhang W, Krishnamoorthy VR, Chavala SH, et al. Hybrid compound SA-2 is neuroprotective in animal models of retinal ganglion cell death. Invest Ophthalmol Vis Sci. 2019;60(8):3064\u201373.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"971_CR32","first-page":"1361","volume":"10","author":"DY Tse","year":"2017","unstructured":"Tse DY, Kim SJ, Chung I, He F, Wensel TG, Wu SM. The ocular toxicity and pharmacokinetics of Simvastatin following intravitreal injection in mice. Int J Ophthalmol. 2017;10(9):1361\u20139.","journal-title":"Int J Ophthalmol"},{"key":"971_CR33","doi-asserted-by":"crossref","unstructured":"Pham JH, Johnson GA, Rangan RS, Amankwa CE, Acharya S, Stankowska DL. Neuroprotection of rodent and human retinal ganglion cells in vitro\/ex vivo by the hybrid small molecule SA-2. Cells. 2022;11(23):3741.","DOI":"10.3390\/cells11233741"},{"key":"971_CR34","unstructured":"Pham J. Timeline of ischemia\/reperfusion (I\/R) study in C57BL\/6J mice. Created in BioRender; 2025 [cited 2025 Aug 10]. Available from: https:\/\/biorender.com\/z57o310"},{"issue":"7","key":"971_CR35","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/02713683.2018.1454478","volume":"43","author":"A Dibas","year":"2018","unstructured":"Dibas A, Millar C, Al-Farra A, Yorio T. Neuroprotective effects of Psalmotoxin-1, an Acid-Sensing ion channel (ASIC) inhibitor, in ischemia reperfusion in mouse eyes. Curr Eye Res. 2018;43(7):921\u201333.","journal-title":"Curr Eye Res"},{"issue":"4","key":"971_CR36","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1167\/iovs.14-13943","volume":"55","author":"TH Chou","year":"2014","unstructured":"Chou TH, Bohorquez J, Toft-Nielsen J, Ozdamar O, Porciatti V. Robust mouse pattern electroretinograms derived simultaneously from each eye using a common snout electrode. Invest Ophthalmol Vis Sci. 2014;55(4):2469\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"971_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-4939-7407-8_6","volume":"1695","author":"TH Chou","year":"2018","unstructured":"Chou TH, Toft-Nielsen J, Porciatti V. High-Throughput binocular pattern electroretinograms in the mouse. Methods Mol Biol. 2018;1695:63\u20138.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"971_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/stem.2722","volume":"36","author":"A Osborne","year":"2018","unstructured":"Osborne A, Sanderson J, Martin KR. Neuroprotective effects of human mesenchymal stem cells and Platelet-Derived growth factor on human retinal ganglion cells. Stem Cells. 2018;36(1):65\u201378.","journal-title":"Stem Cells"},{"issue":"10","key":"971_CR39","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s10792-018-01071-8","volume":"39","author":"X Wang","year":"2019","unstructured":"Wang X, Yuan ZL. Activation of Nrf2\/HO-1 pathway protects retinal ganglion cells from a rat chronic ocular hypertension model of glaucoma. Int Ophthalmol. 2019;39(10):2303\u201312.","journal-title":"Int Ophthalmol"},{"key":"971_CR40","doi-asserted-by":"publisher","first-page":"5695723","DOI":"10.1155\/2020\/5695723","volume":"2020","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yu Y, Lei H, Cai Y, Shen J, Zhu P, et al. The Nrf-2\/HO-1 signaling axis: A ray of hope in cardiovascular diseases. Cardiol Res Pract. 2020;2020:5695723.","journal-title":"Cardiol Res Pract"},{"issue":"8","key":"971_CR41","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1167\/iovs.07-0817","volume":"49","author":"S Berger","year":"2008","unstructured":"Berger S, Savitz SI, Nijhawan S, Singh M, David J, Rosenbaum PS, et al. Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2008;49(8):3605\u201310.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"971_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jconrel.2019.01.012","volume":"297","author":"A Arranz-Romera","year":"2019","unstructured":"Arranz-Romera A, Davis BM, Bravo-Osuna I, Esteban-Perez S, Molina-Martinez IT, Shamsher E, et al. Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma. J Control Release. 2019;297:26\u201338.","journal-title":"J Control Release"},{"issue":"1","key":"971_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41514-024-00155-3","volume":"10","author":"Y Wan","year":"2024","unstructured":"Wan Y, Liu J, Mai Y, Hong Y, Jia Z, Tian G, et al. Current advances and future trends of hormesis in disease. NPJ Aging. 2024;10(1):26.","journal-title":"NPJ Aging"},{"issue":"10","key":"971_CR44","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1021\/jm500258v","volume":"57","author":"X Ning","year":"2014","unstructured":"Ning X, Guo Y, Wang X, Ma X, Tian C, Shi X, et al. Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl Aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents. J Med Chem. 2014;57(10):4302\u201312.","journal-title":"J Med Chem"},{"key":"971_CR45","doi-asserted-by":"crossref","unstructured":"Guo Y, Ma Z, Ning X, Chen Y, Tian C, Wang X et al. A Novel Synthetic Precursor of Styryl Sulfone Neuroprotective Agents Inhibits Neuroinflammatory Responses and Oxidative Stress Damage through the P38 Signaling Pathway in the Cell and Animal Model of Parkinson\u2019s Disease. Molecules. 2021;26(17).","DOI":"10.3390\/molecules26175371"},{"issue":"1","key":"971_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/1570159X19666210617143108","volume":"20","author":"A Diaz-Ruiz","year":"2022","unstructured":"Diaz-Ruiz A, Nader-Kawachi J, Calderon-Estrella F, Mata-Bermudez A, Alvarez-Mejia L, Rios C. Dapsone, more than an effective neuro and cytoprotective drug. Curr Neuropharmacol. 2022;20(1):194\u2013210.","journal-title":"Curr Neuropharmacol"},{"key":"971_CR47","doi-asserted-by":"crossref","unstructured":"Fershtat LL, Zhilin ES. Recent advances in the synthesis and biomedical applications of heterocyclic NO-Donors. Molecules. 2021;26(18).","DOI":"10.3390\/molecules26185705"},{"issue":"1","key":"971_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40662-022-00298-y","volume":"9","author":"L Lambuk","year":"2022","unstructured":"Lambuk L, Suhaimi NAA, Sadikan MZ, Jafri AJA, Ahmad S, Nasir NAA, et al. Nanoparticles for the treatment of glaucoma-associated neuroinflammation. Eye Vis (Lond). 2022;9(1):26.","journal-title":"Eye Vis (Lond)"},{"key":"971_CR49","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.msec.2017.12.036","volume":"92","author":"D Ding","year":"2018","unstructured":"Ding D, Zhu Q. Recent advances of PLGA micro\/nanoparticles for the delivery of biomacromolecular therapeutics. Mater Sci Engineering: C. 2018;92:1041\u201360.","journal-title":"Mater Sci Engineering: C"},{"key":"971_CR50","doi-asserted-by":"publisher","first-page":"114770","DOI":"10.1016\/j.addr.2023.114770","volume":"196","author":"H Han","year":"2023","unstructured":"Han H, Li S, Xu M, Zhong Y, Fan W, Xu J, et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv Drug Deliv Rev. 2023;196:114770.","journal-title":"Adv Drug Deliv Rev"},{"key":"971_CR51","doi-asserted-by":"crossref","unstructured":"Liu LC, Chen YH, Lu DW. Overview of recent advances in Nano-Based ocular drug delivery. Int J Mol Sci. 2023;24(20).","DOI":"10.3390\/ijms242015352"},{"key":"971_CR52","doi-asserted-by":"crossref","unstructured":"Li L, Wang H, Ye J, Chen Y, Wang R, Jin D et al. Mechanism study on nanoparticle negative surface charge modification by ascorbyl palmitate and its improvement of tumor targeting ability. Molecules. 2022;27(14).","DOI":"10.3390\/molecules27144408"},{"issue":"2","key":"971_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"971_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12031-020-01674-w","volume":"71","author":"N Wagner","year":"2021","unstructured":"Wagner N, Reinehr S, Palmhof M, Schuschel D, Tsai T, Sommer E, et al. Microglia activation in retinal ischemia triggers cytokine and Toll-Like receptor response. J Mol Neurosci. 2021;71(3):527\u201344.","journal-title":"J Mol Neurosci"},{"key":"971_CR55","doi-asserted-by":"publisher","first-page":"7812099","DOI":"10.1155\/2022\/7812099","volume":"2022","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chang Y, Han Z, Ma K, Zeng X, Li L. Estrogen protects against renal Ischemia-Reperfusion injury by regulating Th17\/Treg cell immune balance. Dis Markers. 2022;2022:7812099.","journal-title":"Dis Markers"},{"issue":"12","key":"971_CR56","doi-asserted-by":"publisher","first-page":"e0167761","DOI":"10.1371\/journal.pone.0167761","volume":"11","author":"T Luo","year":"2016","unstructured":"Luo T, Liu H, Kim JK. Estrogen protects the female heart from ischemia\/reperfusion injury through manganese superoxide dismutase phosphorylation by mitochondrial p38beta at threonine 79 and Serine 106. PLoS ONE. 2016;11(12):e0167761.","journal-title":"PLoS ONE"},{"issue":"4","key":"971_CR57","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1016\/j.bbrc.2018.07.013","volume":"503","author":"W Li","year":"2018","unstructured":"Li W, Li D, Sun L, Li Z, Yu L, Wu S. The protective effects of Estrogen on hepatic ischemia-reperfusion injury in rats by downregulating the Ang II\/AT1R pathway. Biochem Biophys Res Commun. 2018;503(4):2543\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"971_CR58","first-page":"S62","volume":"20","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE. Effect of postmenopausal hormone therapy on cardiovascular risk. J Hypertens Suppl. 2002;20(2):S62\u20135.","journal-title":"J Hypertens Suppl"},{"issue":"3","key":"971_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of Estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial. JAMA. 2002;288(3):321\u201333.","journal-title":"JAMA"},{"issue":"7","key":"971_CR60","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jama.280.7.605","volume":"280","author":"S Hulley","year":"1998","unstructured":"Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of Estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen\/progestin replacement study (HERS) research group. JAMA. 1998;280(7):605\u201313.","journal-title":"JAMA"},{"issue":"3","key":"971_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/cvr\/cvu064","volume":"102","author":"J Li","year":"2014","unstructured":"Li J, Chen X, McClusky R, Ruiz-Sundstrom M, Itoh Y, Umar S, et al. The number of X chromosomes influences protection from cardiac ischaemia\/reperfusion injury in mice: one X is better than two. Cardiovasc Res. 2014;102(3):375\u201384.","journal-title":"Cardiovasc Res"},{"key":"971_CR62","doi-asserted-by":"publisher","first-page":"1355980","DOI":"10.3389\/fcvm.2024.1355980","volume":"11","author":"J Bridges","year":"2024","unstructured":"Bridges J, Ramirez-Guerrero JA, Rosa-Garrido M. Gender-specific genetic and epigenetic signatures in cardiovascular disease. Front Cardiovasc Med. 2024;11:1355980.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"971_CR63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","volume":"23","author":"NN Osborne","year":"2004","unstructured":"Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23(1):91\u2013147.","journal-title":"Prog Retin Eye Res"},{"key":"971_CR64","doi-asserted-by":"publisher","first-page":"669906","DOI":"10.3389\/fimmu.2021.669906","volume":"12","author":"D Somma","year":"2021","unstructured":"Somma D, Kok FO, Kerrigan D, Wells CA, Carmody RJ. Defining the role of nuclear factor (NF)-kappaB p105 subunit in human macrophage by transcriptomic analysis of NFKB1 knockout THP1 cells. Front Immunol. 2021;12:669906.","journal-title":"Front Immunol"},{"key":"971_CR65","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"971_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13287-020-01816-2","volume":"11","author":"S Shamdani","year":"2020","unstructured":"Shamdani S, Uzan G, Naserian S. TNFalpha-TNFR2 signaling pathway in control of the neural stem\/progenitor cell immunosuppressive effect: different experimental approaches to assess this hypothetical mechanism behind their immunological function. Stem Cell Res Ther. 2020;11(1):307.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"971_CR67","first-page":"1787","volume":"42","author":"G Tezel","year":"2001","unstructured":"Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001;42(8):1787\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"971_CR68","doi-asserted-by":"publisher","first-page":"RC216","DOI":"10.1523\/JNEUROSCI.22-07-j0001.2002","volume":"22","author":"V Fontaine","year":"2002","unstructured":"Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci. 2002;22(7):RC216.","journal-title":"J Neurosci"},{"issue":"43","key":"971_CR69","doi-asserted-by":"publisher","first-page":"12304","DOI":"10.1073\/pnas.1605195113","volume":"113","author":"Y Dong","year":"2016","unstructured":"Dong Y, Fischer R, Naude PJ, Maier O, Nyakas C, Duffey M, et al. Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration. Proc Natl Acad Sci U S A. 2016;113(43):12304\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"971_CR70","doi-asserted-by":"crossref","unstructured":"Chiang SK, Chen SE, Chang LC. The role of HO-1 and its crosstalk with oxidative stress in cancer cell survival. Cells. 2021;10(9).","DOI":"10.3390\/cells10092401"},{"issue":"12","key":"971_CR71","doi-asserted-by":"publisher","first-page":"e114186","DOI":"10.1371\/journal.pone.0114186","volume":"9","author":"H Pan","year":"2014","unstructured":"Pan H, He M, Liu R, Brecha NC, Yu AC, Pu M. Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2\/HO-1 antioxidant pathway. PLoS ONE. 2014;9(12):e114186.","journal-title":"PLoS ONE"},{"issue":"17","key":"971_CR72","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"A Loboda","year":"2016","unstructured":"Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J. Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221\u201347.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"971_CR73","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607\u201332.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-025-00971-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:07:46Z","timestamp":1757412466000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-025-00971-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["971"],"URL":"https:\/\/doi.org\/10.1186\/s12868-025-00971-7","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval were waived for this study due to the use of anonymous human donor eyes according to Sect.\u00a045 CFR 46.104, paragraph (d) (4) (ii) of the Common Rule of the Department of Health and Human Services regulations for the protection of human subjects in research (Title 45 CFR 46, Subpart A). Clinical trial number: not applicable. Informed consent was obtained by the Center for Anatomical Sciences at the University of North Texas Health Science Center (Fort Worth, TX, USA) in accordance with the Declaration of Helsinki. The Institutional Animal Care and Use Committee approved the animal study protocol of the University of North Texas Health Science Center (IACUC 2019-0036, 2023-0005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}